Cargando…
Uncovering therapeutic opportunities in the clinical development of antibody‐drug conjugates
INTRODUCTION: Antibody‐drug conjugates (ADCs) are a family of therapeutic agents that have demonstrated clinical activity in several indications. MATERIAL AND METHODS: In this article, we performed a deep analysis of their clinical landscape matched with public genomic human datasets from tumour ant...
Autores principales: | Nieto‐Jiménez, Cristina, Sanvicente, Adrián, Díaz‐Tejeiro, Cristina, Moreno, Víctor, lopez de Sá, Alfonso, Calvo, Emiliano, Martínez‐López, Joaquín, Pérez‐Segura, Pedro, Ocaña, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517221/ https://www.ncbi.nlm.nih.gov/pubmed/37740463 http://dx.doi.org/10.1002/ctm2.1329 |
Ejemplares similares
-
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities
por: Paniagua-Herranz, Lucía, et al.
Publicado: (2023) -
Genomic mapping of copy number variations influencing immune response in breast cancer
por: López-Cade, Igor, et al.
Publicado: (2022) -
Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
por: Montero, Juan Carlos, et al.
Publicado: (2022) -
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
por: Morafraile, Esther Cabañas, et al.
Publicado: (2023) -
Clinical considerations for the design of PROTACs in cancer
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2022)